HOME >> MEDICINE >> NEWS
Jefferson researchers announce recommendations on when to test blood pressure in young children

Children as young as three years old should have their blood pressure checked as part of their routine pediatric examinations--according to new treatment guidelines to be presented at the American Society of Hypertension's (ASH) Annual Scientific Meeting on Thursday, May 20, in New York City.

"The long-term health risks for hypertensive children and adolescents can be substantial. If left untreated, they pose a growing public health challenge," said Bonita Falkner, M.D., professor of Medicine and Pediatrics at Jefferson Medical College of Thomas Jefferson University in Philadelphia, who chaired the national committee to develop the guidelines. "We want to update clinicians on the latest scientific evidence."

The guidelines are the results of the National High Blood Pressure Education Program Working Group and update previous guidelines from 1996. The complete report is scheduled to be published in the July issue of Pediatrics.

In children and adolescents, the normal range of blood pressure is traditionally determined by body size and age. The guidelines offer blood pressure standards that are based on gender, age and height, which, Dr. Falkner says, provide a more precise classification according to body size and avoid misclassifying children who are very tall or very short.

The guidelines also encourage pediatricians to recommend diet, exercise and weight control counseling for children who fit into a new category known as prehypertension. "The definition of hypertension remains the same," Dr. Falkner says. "Prehypertension refers to an average systolic blood pressure or diastolic blood pressure that is greater than or equal to the 90th percentile, but less than the 95th percentile in children. By adolescence, a blood pressure reading of greater than 120/80 is considered to be prehypertension.

"We know that elevated blood pressure levels in children and adolescents can be associated with obesity and risk factors for diab
'"/>

Contact: Nan Myers
nan.myers@jefferson.edu
215-955-6300
Thomas Jefferson University
18-May-2004


Page: 1 2

Related medicine news :

1. Jefferson Lab medical imager spots breast cancer
2. Jefferson scientists uncover potential trigger of diabetic kidney disease
3. Uric acid may help reduce effects of spinal cord injury, Jefferson researchers find
4. Jefferson scientists help explain statins effects in Alzheimers disease
5. Jefferson scientists find zinc may help prevent esophageal, oral cancers
6. Jefferson virologists coax HIV out of hiding
7. Jefferson scientists find way to see breast cancer activity from outside the body
8. Jefferson and Molecular Targeting Technologies, Inc. scientists create vaccine for wildlife rabies
9. Jefferson scientists use gene therapy to rescue failing hearts in animals
10. Jefferson scientists reveal how some types of rabies invade the brain
11. Jefferson neuroscientists studying new type of Alzheimers drug to halt disease progression

Post Your Comments:
(Date:5/23/2013)... Jim Fitzpatrick just did it again. The ... outside-of-the-box approach to reaching the retail automotive industry. With ... to the retail automotive industry, blending the immediacy of ... format. , CBTNews.com is an innovative website covering ... and Russell Brown host the show with videos, news ...
(Date:5/23/2013)... Coral Springs, FL (PRWEB) May 23, 2013 ... segment about redefining retirement. Many Americans are facing a dim ... stated the Late Boomers -- those born after 1955 -- ... credit card debt. But all hope for The Golden Years ... about how to reduce debt and keep earning after reaching ...
(Date:5/23/2013)... can cause rapidly progressing, life threatening meningitis and meningococcal ... have not known how it attaches to the human ... attaches to the airway to colonise", People can be ... while some people progress to invasive disease. To ... how the bacterium colonises the airway. Now that the ...
(Date:5/23/2013)... HealthDay Reporter , , WEDNESDAY, May 22 (HealthDay News) -- ... detecting lung cancer now have more information to help with ... finds that low-dose CT scans pick up significantly more lung ... history of smoking are at high risk for lung cancer, ... doctors have to consider the potential harm of radiation exposure ...
(Date:5/23/2013)... Los Angeles,Ca (PRWEB) May 23, 2013 ... with removing every sign associated with Rosacea. This condition ... skin and can affect a person’s self-image. Manufacturers have ... work to help constrict blood vessels near the surface ... and flushing. The new formula is available with special ...
Breaking Medicine News(10 mins):Health News:Fitzpatrick Advertising Founder Brings Auto Industry into Focus with CBT News 2Health News:Viewpoints with Terry Bradshaw Presents a Series on Redefining Retirement 2Health News:New discovery in fight against deadly meningococcal disease 2Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 2Health News:CT Scans Reduce Lung Cancer Deaths, Study Confirms 3Health News:Revitol Rosacea Now Comes with Anti-Inflammatory Ingredients to Remove Redness and Flushing 2
(Date:5/23/2013)... 2013  Omeros Corporation (NASDAQ: OMER ... Application (IND) to evaluate OMS824 in Huntington,s disease ... Drug Administration (FDA). OMS824 selectively inhibits phosphodiesterase 10 ... brain linked to a wide range of diseases ... OMS824 has shown promising results in animal models ...
(Date:5/23/2013)... -- Echo Pharma Acquisition Limited ("Royalty Pharma") announced today that ... from 90 percent to 50 percent of Maximum Elan ... the terms of the Revised Offer Document issued today, ... the terms of the Increased Offer, Royalty Pharma is ... for $12.50 per share in cash. The Increased Offer ...
(Date:5/23/2013)... Engeland, May 23, 2013 Nederland ... met lagere urinewegsymptomen geassocieerd met BPH Astellas ... dochteronderneming van Astellas Pharma Inc, gebaseerd in ... kondigde vandaag aan dat het Nederlandse College ter Beoordeling ... in Nederland. De handelsvergunning verleend voor VESOMNI ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 2Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 3Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 4
Cached News: